Am. J. Respir. Crit. Care Med., Volume 162, Number 4, October 2000, 1524-1533

Commercial versus Native Surfactants
Surface Activity, Molecular Components, and the Effect of Calcium

WOLFGANG BERNHARD, JASMIN MOTTAGHIAN, ANDREAS GEBERT, GUNNAR A. RAU, HORST von der HARDT, and CHRISTIAN F. POETS

Departments of Pediatric Pulmonology and Neonatology and Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany

Despite their broad clinical use, there is no standardized comparative study on the functional, biochemical, and morphologic differences of the various commercial surfactants in relation to native surfactant. We investigated these parameters in Alveofact, Curosurf, Exosurf, and Survanta, and compared them with native bovine (NBS) and porcine (NPS) surfactant. For Curosurf and Alveofact the concentrations necessary for minimal surface tensions < 5 mN/m were six to 12 times higher (1.5 and 3 mg/ml, respectively) than with NPS and NBS. Exosurf and Survanta only reached 22 and 8 mN/m, respectively. Increasing calcium to nonphysiologic concentrations artificially improved the function of Alveofact and Curosurf, but it had little effect on Exosurf and Survanta. Impaired surface activity of commercial versus native surfactants corresponded with their lack in surfactant protein SP-A and decreased SP-B/C. The higher surface activity of Curosurf compared with Alveofact corresponded with its higher concentration of dipalmitoylphosphatidylcholine (DPPC). Despite their enrichment in DPPC Survanta and Exosurf exhibited poor surface activity because of low or absent SP-B/C. Ultrastructurally, Curosurf and Alveofact consisted mainly of lamellar and vesicular structures, which were also present in NPS and NBS. Exosurf contained crystalline structures only, whereas the DPPC-enriched Survanta contained separate lamellar/vesicular and crystalline structures. We conclude that in vitro surface activity of commercial surfactants is impaired compared with native surfactants at physiologic calcium concentrations. In the presence of SP-B/C, surface activity corresponds to the concentration of DPPC. Our data underscore the importance of a standardized protocol at physiologic calcium concentrations for the in vitro assessment of commercial surfactants.

This article has been cited by other articles:

				A. Almlen, G. Stichtenoth, B. Linderholm, M. Haegerstrand-Bjorkman, B. Robertson, J. Johansson, and T. Curstedt Surfactant proteins B and C are both necessary for alveolar stability at end expiration in premature rabbits with respiratory distress syndrome J Appl Physiol, April 1, 2008; 104(4): 1101 - 1108. [Abstract] [Full Text] [PDF]

				C. Gille, B. Spring, W. Bernhard, C. Gebhard, D. Basile, K. Lauber, C. F. Poets, and T. W. Orlikowsky Differential effect of surfactant and its saturated phosphatidylcholines on human blood macrophages J. Lipid Res., February 1, 2007; 48(2): 307 - 317. [Abstract] [Full Text] [PDF]

				R. Koetzler, M. Saifeddine, Z. Yu, F.S. Schurch, M. D. Hollenberg, and F. H. Y. Green Surfactant as an Airway Smooth Muscle Relaxant Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 609 - 615. [Abstract] [Full Text] [PDF]

				A. Wemhoner, M. Frick, P. Dietl, P. Jennings, and T. Haller A Fluorescent Microplate Assay for Exocytosis in Alveolar Type II Cells J Biomol Screen, April 1, 2006; 11(3): 286 - 295. [Abstract] [PDF]

				R. Ridsdale, M. Roth-Kleiner, F. D'Ovidio, S. Unger, M. Yi, S. Keshavjee, A. K. Tanswell, and M. Post Surfactant Palmitoylmyristoylphosphatidylcholine Is a Marker for Alveolar Size during Disease Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 225 - 232. [Abstract] [Full Text] [PDF]

				M. Rudiger, A. Tolle, W. Meier, and B. Rustow Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L379 - L383. [Abstract] [Full Text] [PDF]

				W. Bernhard, C. J. Pynn, A. Jaworski, G. A. Rau, J. M. Hohlfeld, J. Freihorst, C. F. Poets, D. Stoll, and A. D. Postle Mass Spectrometric Analysis of Surfactant Metabolism in Human Volunteers Using Deuteriated Choline Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 54 - 58. [Abstract] [Full Text] [PDF]

				R. G. Spragg, P. J. Ponganis, J. J. Marsh, G. A. Rau, and W. Bernhard Surfactant from diving aquatic mammals J Appl Physiol, May 1, 2004; 96(5): 1626 - 1632. [Abstract] [Full Text] [PDF]

				G. A. Rau, G. Vieten, J. J. Haitsma, J. Freihorst, C. Poets, B. M. Ure, and W. Bernhard Surfactant in Newborn Compared with Adolescent Pigs: Adaptation to Neonatal Respiration Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 694 - 701. [Abstract] [Full Text] [PDF]

				A. K. Panda, K. Nag, R. R. Harbottle, K. Rodriguez-Capote, R. A. W. Veldhuizen, N. O. Petersen, and F. Possmayer Effect of Acute Lung Injury on Structure and Function of Pulmonary Surfactant Films Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 641 - 650. [Abstract] [Full Text] [PDF]

				V. J. Erpenbeck, A. Hagenberg, Y. Dulkys, J. Elsner, R. Balder, H. Krentel, M. Discher, A. Braun, N. Krug, and J. M. Hohlfeld Natural Porcine Surfactant Augments Airway Inflammation after Allergen Challenge in Patients with Asthma Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 578 - 586. [Abstract] [Full Text] [PDF]

				W. Bernhard, P. L. Haslam, and J. Floros From Birds to Humans: New Concepts on Airways Relative to Alveolar Surfactant Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 6 - 11. [Abstract] [Full Text] [PDF]

				J. Johansson, M. Some, B.-M. Linderholm, A. Almlen, T. Curstedt, and B. Robertson A synthetic surfactant based on a poly-Leu SP-C analog and phospholipids: effects on tidal volumes and lung gas volumes in ventilated immature newborn rabbits J Appl Physiol, November 1, 2003; 95(5): 2055 - 2063. [Abstract] [Full Text] [PDF]

				P. L. Ballard, J. D. Merrill, R. I. Godinez, M. H. Godinez, W. E. Truog, and R. A. Ballard Surfactant Protein Profile of Pulmonary Surfactant in Premature Infants Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1123 - 1128. [Abstract] [Full Text] [PDF]

				Z. Wang, J. E. Baatz, B. A. Holm, and R. H. Notter Content-dependent activity of lung surfactant protein B in mixtures with lipids Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L897 - L906. [Abstract] [Full Text] [PDF]

				W. Bernhard, S. Hoffmann, H. Dombrowsky, G. A. Rau, A. Kamlage, M. Kappler, J. J. Haitsma, J. Freihorst, H. von der Hardt, and C. F. Poets Phosphatidylcholine Molecular Species in Lung Surfactant . Composition in Relation to Respiratory Rate and Lung Development Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 725 - 731. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1581 - 1594. [Full Text] [PDF]